Article info

Download PDFPDF

Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

Authors

Citation

Drent E, Groen R, Noort W, et al
Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

Publication history

  • First published November 4, 2015.
Online issue publication 
November 04, 2015

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.